318 related articles for article (PubMed ID: 31725448)
1. Effect of endostatin overexpression on angiotensin II-induced cardiac hypertrophy in rats.
Dai YJ; Gong JX; Bian R
Chin Med J (Engl); 2019 Nov; 132(22):2716-2723. PubMed ID: 31725448
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-(3-7) alleviates isoprenaline-induced cardiac remodeling via attenuating cAMP-PKA and PI3K/Akt signaling pathways.
Zhang Y; Shang Z; Liu A
Amino Acids; 2021 Oct; 53(10):1533-1543. PubMed ID: 34494132
[TBL] [Abstract][Full Text] [Related]
4. Alarin moderated myocardial hypertrophy via inhibiting cyclic adenosine monophosphate/protein kinase A signaling pathway to attenuate autophagy.
Shen T; Liu Y; Dong S; Xu X; Wang X; Li Y; Zhou L
Peptides; 2021 Dec; 146():170669. PubMed ID: 34624429
[TBL] [Abstract][Full Text] [Related]
5. GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.
Zhang C; Wang Y; Ge Z; Lin J; Liu J; Yuan X; Lin Z
Curr Mol Med; 2018; 18(10):661-671. PubMed ID: 30714521
[TBL] [Abstract][Full Text] [Related]
6. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
Yin Z; Wang X; Zhang L; Zhou H; Wei L; Dong X
Cardiovasc Ther; 2016 Feb; 34(1):21-9. PubMed ID: 26506219
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional cofactor dyxin mediates hypertrophic response in the heart during angiotensin II-induced hypertension.
Sakkinen H; Luosujarvi H; Karvonen T; Mustonen E; Moilanen AM; Aro J; Napankangas J; Ruskoaho H; Rysa J
J Physiol Pharmacol; 2023 Dec; 74(6):. PubMed ID: 38345442
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.
Li Y; Cai X; Guan Y; Wang L; Wang S; Li Y; Fu Y; Gao X; Su G
PLoS One; 2016; 11(2):e0148482. PubMed ID: 26845040
[TBL] [Abstract][Full Text] [Related]
9. Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways.
Chen G; Pan SQ; Shen C; Pan SF; Zhang XM; He QY
Acta Pharmacol Sin; 2014 Apr; 35(4):463-75. PubMed ID: 24608673
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Dracocephalum Heterophyllum Benth Flavonoid on Hypertrophic Cardiomyocytes Induced by Angiotensin II in Rats.
Jiang H; Zhang C; He W
Med Sci Monit; 2018 Sep; 24():6322-6330. PubMed ID: 30199522
[TBL] [Abstract][Full Text] [Related]
11. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
[TBL] [Abstract][Full Text] [Related]
12. AdipoRon prevents l-thyroxine or isoproterenol-induced cardiac hypertrophy through regulating the AMPK-related pathway.
Hu X; Ou-Yang Q; Wang L; Li T; Xie X; Liu J
Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):20-30. PubMed ID: 30566571
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type-1 receptor-JAK/STAT pathway mediates the induction of visfatin in angiotensin II-induced cardiomyocyte hypertrophy.
Chang L; Yang R; Wang M; Liu J; Wang Y; Zhang H; Li Y
Am J Med Sci; 2012 Mar; 343(3):220-6. PubMed ID: 21841463
[TBL] [Abstract][Full Text] [Related]
14. Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats.
Liu C; Yang CX; Chen XR; Liu BX; Li Y; Wang XZ; Sun W; Li P; Kong XQ
Amino Acids; 2018 Aug; 50(8):1071-1081. PubMed ID: 29752563
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
[TBL] [Abstract][Full Text] [Related]
16. NLRC5 enhances autophagy via inactivation of AKT/mTOR pathway and ameliorates cardiac hypertrophy.
Ba B; Mayila A; Guo Y; Xu J; Xing S; Cao G
Int J Exp Pathol; 2022 Feb; 103(1):23-30. PubMed ID: 34802165
[TBL] [Abstract][Full Text] [Related]
17. Crucial Role of ROCK2-Mediated Phosphorylation and Upregulation of FHOD3 in the Pathogenesis of Angiotensin II-Induced Cardiac Hypertrophy.
Zhou Q; Wei SS; Wang H; Wang Q; Li W; Li G; Hou JW; Chen XM; Chen J; Xu WP; Li YG; Wang YP
Hypertension; 2017 Jun; 69(6):1070-1083. PubMed ID: 28438902
[TBL] [Abstract][Full Text] [Related]
18. [Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A].
Zhou DX; Liang QS; He XX; Zhan CY
Zhongguo Zhong Yao Za Zhi; 2008 Apr; 33(8):936-9. PubMed ID: 18619357
[TBL] [Abstract][Full Text] [Related]
19. Polydatin prevents angiotensin II-induced cardiac hypertrophy and myocardial superoxide generation.
Zhang Q; Tan Y; Zhang N; Yao F
Exp Biol Med (Maywood); 2015 Oct; 240(10):1352-61. PubMed ID: 25488910
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of farnesylpyrophosphate synthase prevents angiotensin II-mediated cardiac hypertrophy.
Ye Y; Mou Y; Bai B; Li L; Chen GP; Hu SJ
Int J Biochem Cell Biol; 2010 Dec; 42(12):2056-64. PubMed ID: 20884373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
